M A Frye

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics
    M A Frye
    National Institute of Mental Health, Biological Psychiatry Branch, Bethesda, MD, USA
    J Affect Disord 48:91-104. 1998
  2. ncbi Gabapentin does not alter single-dose lithium pharmacokinetics
    M A Frye
    Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892, USA
    J Clin Psychopharmacol 18:461-4. 1998
  3. ncbi The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients
    T Suppes
    The Stanley Foundation Bipolar Network, 5430 Grosvenor Lane, Suite 200, Bethesda, MD 20814, USA
    J Affect Disord 67:45-59. 2001
  4. ncbi The Stanley Foundation Bipolar Network. I. Rationale and methods
    R M Post
    National Institute of Mental Health, Bethesda, Maryland, USA
    Br J Psychiatry Suppl 41:s169-76. 2001
  5. ncbi Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers
    R M Post
    Biological Psychiatry Branch, NIMH, NIH, Bethesda, MD 20892-1272, USA
    Bipolar Disord 3:259-65. 2001
  6. ncbi Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men
    E A Osuch
    Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
    Acta Psychiatr Scand 104:397-401. 2001
  7. ncbi Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
    R M Post
    Department of Health and Human Services, National Institute of Mental Health, Bethesda, Maryland, USA
    Br J Psychiatry 189:124-31. 2006
  8. ncbi Elevated concentration of N-CAM VASE isoforms in schizophrenia
    M P Vawter
    Cellular Neurobiology Branch, NIDA IRP, Baltimore, MD 21224, USA
    J Psychiatr Res 34:25-34. 2000
  9. ncbi Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression
    M Bauer
    Neuropsychiatric Institute and Hospital, University of California Los Angeles, CA, USA
    Mol Psychiatry 10:456-69. 2005
  10. ncbi Use of quetiapine in bipolar disorder: a case series with prospective evaluation
    T Suppes
    Int Clin Psychopharmacol 19:173-4. 2004

Detail Information

Publications11

  1. ncbi Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics
    M A Frye
    National Institute of Mental Health, Biological Psychiatry Branch, Bethesda, MD, USA
    J Affect Disord 48:91-104. 1998
    ..The foregoing agents and future drugs with atypical neuroleptic properties should come to play an increasingly important role, compared to the older classical neuroleptics, in the acute and long term management of bipolar disorder...
  2. ncbi Gabapentin does not alter single-dose lithium pharmacokinetics
    M A Frye
    Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892, USA
    J Clin Psychopharmacol 18:461-4. 1998
    ....
  3. ncbi The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients
    T Suppes
    The Stanley Foundation Bipolar Network, 5430 Grosvenor Lane, Suite 200, Bethesda, MD 20814, USA
    J Affect Disord 67:45-59. 2001
    ..This report describes the demographics and course of illness characteristics of this study population...
  4. ncbi The Stanley Foundation Bipolar Network. I. Rationale and methods
    R M Post
    National Institute of Mental Health, Bethesda, Maryland, USA
    Br J Psychiatry Suppl 41:s169-76. 2001
    ..CONCLUSIONS: Well-characterised patients are followed in a detailed continuous longitudinal fashion in both opportunistic case series and double-blind, randomised controlled trials with reliable and validated measures...
  5. ncbi Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers
    R M Post
    Biological Psychiatry Branch, NIMH, NIH, Bethesda, MD 20892-1272, USA
    Bipolar Disord 3:259-65. 2001
    ..Individual data on each drug will be assessed in the next phase of the study after more subjects are recruited and the blind is broken...
  6. ncbi Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men
    E A Osuch
    Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
    Acta Psychiatr Scand 104:397-401. 2001
    ..CONCLUSION: The pathophysiological implications of this selective positive relationship between severity of depression and post-DST cortisol in women, but not men, should be explored further...
  7. ncbi Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
    R M Post
    Department of Health and Human Services, National Institute of Mental Health, Bethesda, Maryland, USA
    Br J Psychiatry 189:124-31. 2006
    ..Few studies have examined the relative risks of switching into hypomania or mania associated with second-generation antidepressant drugs in bipolar depression...
  8. ncbi Elevated concentration of N-CAM VASE isoforms in schizophrenia
    M P Vawter
    Cellular Neurobiology Branch, NIDA IRP, Baltimore, MD 21224, USA
    J Psychiatr Res 34:25-34. 2000
    ..These results provide further evidence of an abnormality of N-CAM protein in chronic schizophrenia and suggest differences between schizophrenia and affective disorders in regulation of N-CAM...
  9. ncbi Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression
    M Bauer
    Neuropsychiatric Institute and Hospital, University of California Los Angeles, CA, USA
    Mol Psychiatry 10:456-69. 2005
    ..We conclude that bipolar depressed patients have abnormal function in prefrontal and limbic brain areas. L-T(4) may improve mood by affecting circuits involving these areas, which have been previously implicated in affective disorders...
  10. ncbi Use of quetiapine in bipolar disorder: a case series with prospective evaluation
    T Suppes
    Int Clin Psychopharmacol 19:173-4. 2004
    ..Somatic complaints were limited. Mean (SD) duration before changes in medication regimens was 134 (100) days. Studies of the use of quetiapine in maintenance treatment of bipolar disorder are warranted...
  11. ncbi Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study
    W A Nolen
    University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Acta Psychiatr Scand 115:360-5. 2007
    ..To compare the efficacy and tolerability of tranylcypromine vs. lamotrigine in bipolar depression not responding to conventional antidepressants...